Ionis Pharmaceuticals | IONS - Interest Expense On Debt

Stock Price
84.91
Daily Change
1.84 2.22%
Monthly
8.12%
Yearly
168.36%
Q1 Forecast
80.12

Ionis Pharmaceuticals reported $18M in Interest Expense on Debt for its fiscal quarter ending in September of 2025.





Interest Expense On Debt Change Date
Agios Pharmaceuticals USD 1.39B 85.53M Sep/2025
Alnylam Pharmaceuticals USD 44.4M 4.15M Sep/2025
Arrowhead Research USD 21.69M 2.69M Sep/2025
Astellas Pharma JPY 3.91B 320M Mar/2025
BioMarin Pharmaceutical USD 2.58M 100K Sep/2025
Celltrion KRW 19B 1.96B Jun/2025
Cspc Pharmaceutical CNY 10.19M 4.73M Sep/2025
Divis Laboratories Ltd INR 30M 20M Jun/2025
Exelixis USD 23.4M 3.9M Sep/2023
Halozyme Therapeutics USD 4.3M 98K Sep/2025
Ionis Pharmaceuticals USD 18M 1000K Sep/2025
Kangmei Pharma CNY 1.82M 150K Sep/2025
Knight Therapeutics CAD 2.37M 6K Sep/2025
Laboratorios Farma EUR 699K 666.2K Jun/2025
Medical Developments International AUD 18K 3K Jun/2025
Moderna USD 12.14B 12.13B Sep/2025
Neuren Pharmaceuticals AUD 0 0 Jun/2024
Neurocrine Biosciences USD 1.1M 0 Mar/2024
Novartis USD 281M 8M Sep/2025
OPKO Health USD 10.76M 59.57M Sep/2025
Pfizer USD 652M 2M Sep/2025
Pharma Mar EUR 117K 1.24M Sep/2025
PTC Therapeutics USD 2.64B 2.61B Sep/2025
Qiagen NV USD 8.22M 615K Sep/2025
Regeneron Pharmaceuticals USD 12.2M 7.1M Dec/2025
Roche Holding CHF 304M 7.5M Jun/2025
Sarepta Therapeutics USD 7.56M 2.33M Sep/2025
Sartorius EUR 49.5M 8.1M Sep/2025
Sino Biopharmaceutical CNY 76.87M 114.23M Jun/2024
Tilray USD 6.7M 2.73M Jun/2025
Ultragenyx Pharmaceutical USD 14.15M 108K Sep/2025
Vertex Pharmaceuticals USD 3.3M 400K Sep/2025
Zz Pientze Pharmaceu CNY 46.05M 36.5M Jun/2025